• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Czech gunmaker bets on riding Colt into new markets

September 13, 2021 by David Barret Leave a Comment

September 13, 2021

By Michael Kahn and Jason Hovet

PRAGUE (Reuters) – For Czech gun maker CZG-Ceska Zbrojovka Group, its recent acquisition of the Colt brand carries both the potential to become a major player in the global firearms market and the challenge of reviving the fortunes of a fabled U.S. name.

Shares of CZG, which listed on the stock market last October, have surged 60% in Prague this year as investors welcomed solid revenue growth and the company’s $222 million purchase of privately-held Colt Holding Company – a deal finalised in May that will make CZG a competitor for U.S. leaders such as Smith & Wesson and Sturm, Ruger & Company.

Colt, with plants in the United States and Canada, will give CZG the capacity to expand production beyond its main factory in the Czech Republic and allow it to compete in U.S. military contracts because it will fulfil “Buy America” regulations requiring U.S. production.

CZG says it aims to almost double CZG and Colt’s pro-forma combined revenue of around $570 million last year within a few years – putting it on a par with Smith & Wesson’s annual net sales of $1.1 billion in the last fiscal year.

In 2020, the United States accounted for 66% of the Czech gunmaker’s annual revenue, mainly sales to individuals and police departments of guns under its CZ (Ceska Zbrojovka), Dan Wesson and Brno Rifles brands.

“Colt is an important step in realising our vision of getting to 1 billion (euros) in revenue by the end of 2025,” CZG’s Chairman Jan Drahota told Reuters in an interview at the company’s Prague headquarters.

“We … will be thinking how to make sure the brand is even bigger than it is now and introduce it to wider (markets).

“It is a privilege, but it is also pressure on us,” he said.

Some of the pressure could come from investors. The revenue target looks ambitious to some analysts and will require investment by CZG, whose roots stretch back to before World War II.

“It is definitely an ambitious goal,” said Pavel Ryska, analyst at J&T Banka in Prague. “In my view, it could be met on two conditions. First, the U.S. civilian demand remains robust and keeps rising, and second, CZG adds further production capacity either through its own capex or through additional acquisitions that are well executed.”

Founded by Samuel Colt, the U.S. company produced one of the first revolvers and its single-action revolver known as “The Peacemaker” was synonymous with lawmen and outlaws in the Wild West in the 19th century. By 2015, however, the company was filing for bankruptcy protection following a series of missteps and the loss of a key contract with the U.S. Army.

Those issues allowed rivals to steal a march on Colt, although it emerged from bankruptcy in 2016 and revenue rose by a quarter last year.

UNDERINVESTMENT

CZG, which used IPO proceeds and issued bonds to help finance the Colt deal, will outline investment plans later this year. They will include possibly introducing new products and investing in upgrades at Colt’s main factory in West Hartford, Connecticut, Drahota said.

Upgrades will also mean “essentially an enlargement of capacity because of underinvestment in the past,” he said.

CZG is also considering whether to produce some CZG products in the United States, he said, adding there is little overlap with Colt products.

“We have to consider from a group level what … the production split will be at each location,” he said. “One plus one is more than two. We believe we can leverage on each other’s success.”

About half of Colt’s revenues in 2020 came from the massive U.S. military and law enforcement (M&LE) segment and Drahota said he saw “huge room” to grow the brand in global civilian and M&LE markets.

Analysts at Czech-based Fio Banka estimate the military and law enforcement portion of CZG’s North American sales will climb to 50% from 10% with the Colt acquisition, boosting the company’s revenue as M&LE firearms fall into higher price categories.

Global demand for small firearms is expected to rise from around 1.09 billion units in 2019 to 1.26 billion units in 2023, CZG said in its annual report, citing the BIS Small Arms Market Report, with the civilian market now accounting for 62% of sales and military and law enforcement 38%.

The market’s good growth prospects have helped drive shares of Smith & Wesson and Sturm, Ruger & Co. up 21% and 16% respectively this year.

CZG, whose operating profit rose 12% last year, has until now mainly competed with European groups like FN Herstal of Belgium, Beretta of Italy and Glock Gesellschaft of Austria and struck deals last year with the Czech Army and law enforcement bodies in Brazil and Kenya, as well as contracts to help rearm Hungary’s army.

Buying Colt will also give it exposure to the UK and Canadian militaries, among others, and Drahota said the market will continue to shift to more advanced weapons as demanded by military customers. CZG, which last year took a minority stake in Spuhr i Dalby AB, a Swedish maker of optical mounting solutions for weapons, would also look at further acquisitions, especially in areas like optics or optoelectronics.

“We want to grow by acquisitions but we will be disciplined,” Drahota said.

($1 = 21.4970 Czech crowns)

(Reporting by Michael Kahn and Jason Hovet; Editing by Susan Fenton)

Source Link Czech gunmaker bets on riding Colt into new markets

David Barret
David Barret

Related posts:

  1. Virgin Galactic to launch first commercial research mission
  2. Brits want their next smartphone to be environmentally conscious
  3. China’s Alibaba to invest $15.5 billion for “common prosperity”
  4. Tennis-Federer tops Forbes’ list of top-earning tennis players

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • The First Humans Were Hunted By Leopards, Scientists Have No Clue What These Marine “Y-Larvae” Grow Into, And Much More This Week
  • Operation Beluga: In 1985, An Icebreaker Playing Classical Music Saved 2,000 Beluga Whales From Certain Death
  • Getting Bats Drunk, Lizards’ Pizza Preferences, And Praising Narcissists Win Big At 2025 Ig Nobel Awards
  • Who Was The First Person To See The Moon Through A Telescope?
  • How Do You Weigh A Single Cell? Turns Out, There’s A Few Options
  • Should We Sleep Outside? Turns Out There Are Some Benefits
  • A US Federal Committee Is Meeting To Discuss Vaccines – Here’s What You Should Know
  • Neanderthal Noises, Dome-Headed Dinosaurs, And Mystery Larvae
  • Over Half Of Migrating Wildebeests Are Seemingly “Missing” In Latest Survey
  • Meet The Chewbacca Coral, A Ridiculously Fluffy New Species Discovered In The Deep Sea
  • Why Are School Buses Painted Yellow In The US?
  • What Are The Symptoms Of The “Stratus” COVID-19 Subvariant That’s Hitting The USA?
  • Intrepid Jaguar Swims Over 1 Kilometer, Smashing Previous Distance Record By More Than 6 Times
  • Breakthrough 3D Bioprinted Mini Placentas May Help Solve “One Of Medicine’s Great Mysteries”
  • Meet The “Grue Jay”: A Bizarre Rare Bird Spotted In Texas Is A Unique Hybrid Of Two Different Species
  • 21 Grams Experiment: In 1907, A Doctor Tried To Prove The Existence Of The Soul Using Weighing Scales
  • The World’s Oldest Known Cake Is Over 4,000 Years Old, And It Sounds Pretty Delicious
  • An Ominous Haze Lurks Over The Deadliest Volcano In US, But USGS Says A Repeat Of 1980 Isn’t Coming
  • Hayabusa2’s Target Asteroid Is 4 Times Smaller Than Thought – Can It Still Touch Down On It?
  • In 2011, Slavc The Wolf Journeyed 1,000 Miles To Begin Verona’s First Wolf Pack In 100 Years
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version